BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25338583)

  • 1. [Effects of sorafenib on proliferation and apoptosis of human multiple myeloma cell RPMI 8226].
    Zhou NC; Liu BL; Qi MY; Xu B; Liu X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1331-5. PubMed ID: 25338583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of oxaliplatin-induced apoptosis of human multiple myeloma cell RPMI8226].
    Liu BL; Liu X; Zhou NC; Qi MY; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):99-104. PubMed ID: 23484700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of mitoxantrone on proliferation and apoptosis of human multiple myeloma cell RPMI8226].
    Qi MY; Liu X; Liu BL; Zhou NC; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1633-9. PubMed ID: 25543488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of docetaxel on proliferation and apoptosis of human multiple myeloma cell RPMI8226].
    Liu BL; Liu X; Qi MY; Zhou NC; Xu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1378-83. PubMed ID: 23257437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis.
    Ramírez-Labrada A; López-Royuela N; Jarauta V; Galán-Malo P; Azaceta G; Palomera L; Pardo J; Anel A; Marzo I; Naval J
    Clin Transl Oncol; 2015 Feb; 17(2):121-32. PubMed ID: 25037851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of cladribine-inducing apoptosis of multiple myeloma RPMI 8226 cells in vitro].
    Zhou NC; Qi MY; Liu BL; Xu B; Liu X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1644-8. PubMed ID: 25543490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of beta-elemene on proliferation and apoptosis of human multiple myeloma cell RPMI-8226].
    Chen H; Shi L; Cheng ZY; Yao L; Yang YY; Pan L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):368-71. PubMed ID: 20416170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
    Zhou XJ; Zhou YH; Chen XH; Qian WB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
    Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
    J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
    Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
    Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3.
    Lin L; Chen D; Xiang ZF; Pei RZ; Zhang PS; Liu XH; Du XH; Lu Y
    Cancer Biomark; 2017 Aug; 20(2):217-224. PubMed ID: 28869453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer.
    Ruan M; Liu M; Dong Q; Chen L
    J Clin Endocrinol Metab; 2015 May; 100(5):1771-9. PubMed ID: 25768669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of sorafenib induced NB4 cell apoptosis].
    Zhang YJ; Liu X; Song YP; Li GC; Zhou NC; Wang H; Wang QX; Xie J; Li G; Ren JJ; Gao F; Zhang XB; Dai JQ; Wang L; Mu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):77-82. PubMed ID: 25687050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoptosis of multiple myeloid cells induced by polysaccharides extracts from Hedyotis diffusa and its mechanism].
    Lin SY; Shen CY; Jiang JP; Wu LQ; Dai TY; Qian WB; Meng HT
    Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):337-40. PubMed ID: 23668208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.
    Sun NK; Huang SL; Chang TC; Chao CC
    J Cell Biochem; 2013 Aug; 114(8):1819-31. PubMed ID: 23463670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
    Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
    Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1082-39, an analogue of sorafenib, inhibited human cancer cell growth more potently than sorafenib.
    Chu JH; Zhao CR; Song ZY; Wang RQ; Qin YZ; Li WB; Qu XJ
    Biomed Pharmacother; 2014 Apr; 68(3):335-41. PubMed ID: 24581722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
    Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
    BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway.
    Lin MT; Lin CL; Lin TY; Cheng CW; Yang SF; Lin CL; Wu CC; Hsieh YH; Tsai JP
    Tumour Biol; 2016 May; 37(5):6987-96. PubMed ID: 26662956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.